Finance

Beta
Lists
ALA:ASX
Arovella Therapeutics Ltd
0,069 A$
0,00%
(0,00) 1D
3 հլս, 16:00:00 GMT+10  ·   AUD
All symbols
SymbolPriceChange% Change
Generating top insights for ALA...
Open
0,07 A$
High
0,07 A$
Low
0,07 A$
Mkt. cap
82,22 մլն
Avg. vol.
1,02 մլն
Volume
906,00 հզր
52-wk high
0,12 A$
52-wk low
0,06 A$
EPS
-0,01 A$
Shares outstanding
1,21 մլրդ
No. of employees
14
Open
0,07 A$
High
0,07 A$
Low
0,07 A$
Mkt. cap
82,22 մլն
Avg. vol.
1,02 մլն
Volume
906,00 հզր
52-wk high
0,12 A$
52-wk low
0,06 A$
EPS
-0,01 A$
Shares outstanding
1,21 մլրդ
No. of employees
14
News stories
From sources across the web
About Arovella Therapeutics Ltd
CEOMichael Baker
Employees14
Founded1999
Headquarters-
Sector-
Last report
23 հնվ, 2026 թ.
Fiscal period
Q2 2026
EPS / Est. (AUD)
- / -
Revenue / Est. (AUD)
1,60 մլն / -
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in AUD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in AUD
2025 թ. մրտ
2025 թ. հնս
2025 թ. սեպ
2025 թ. դեկ
Revenue
415,00
415,00
1,60 մլն
1,60 մլն
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
1,97 մլն
1,97 մլն
1,37 մլն
1,37 մլն
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
523,20 հզր
523,20 հզր
721,91 հզր
721,91 հզր
Operating expense
3,10 մլն
3,10 մլն
2,75 մլն
2,75 մլն
Total operating expenses
3,10 մլն
3,10 մլն
2,75 մլն
2,75 մլն
Operating income
-3,10 մլն
-3,10 մլն
-1,15 մլն
-1,15 մլն
Other non operating income
-
-
-
-
EBT including unusual items
-3,02 մլն
-3,02 մլն
-939,35 հզր
-939,35 հզր
EBT excluding unusual items
-3,02 մլն
-3,02 մլն
-939,35 հզր
-939,35 հզր
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
402,20 հզր
402,20 հզր
449,58 հզր
449,58 հզր
Net income
-3,02 մլն
-3,02 մլն
-939,35 հզր
-939,35 հզր
Net profit margin
-728 624,58%
-728 624,58%
-58,55%
-58,55%
Earnings per share
-
-
-
-
Interest and investment income
72,24 հզր
72,24 հզր
207,81 հզր
207,81 հզր
Interest expense
-
-
-
-
Net interest expenses
72,24 հզր
72,24 հզր
207,81 հզր
207,81 հզր
Depreciation and amortization charges
29,20 հզր
29,20 հզր
29,58 հզր
29,58 հզր
EBITDA
-3,07 մլն
-3,07 մլն
-1,12 մլն
-1,12 մլն
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more

Research

What's on your mind?
What's going on with the markets today?
Explore what’s possible
Deep Search
AI content may include mistakes. Learn more